Hypoglycemic, hypolipidemic and antioxidant activities of Cleome droserifolia in streptozotocin-diabetic rats

Hypoglycemic, hypolipidemic and antioxidant activities of Cleome droserifolia in streptozotocin-diabetic rats

Автор: El-khawaga Omali Y., Abou-seif M.a, El-waseef A., Negm A.a

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 4 т.6, 2010 года.

Бесплатный доступ

Background: Diabetes mellitus (DM) is characterized by absolute or relative deficiencies in insulin secretion and/or insulin action associated with chronic hypoglycemia clinical research has confirmed the efficacy of several plant extracts in the amelioration of diabetic disorders. Aim of the work hypolipidemic and antioxidant activities of the aqueous extract of Cleome droseriloia was investigated in streptozotocin (STZ)-induced diabetic rats. Methods and Results: A single dose of STZ (60mg/Kg body weight) produced a decrease in hepatic glycogen and GSH contents, hepatic glucose-6-phosphate dehydrogenase, superoxide dismutase, activities and HDL- cholesterol, whereas, hepatic glucose-6-phosphatase activity and level of MDA, cholesterol, triglyceride, LDL-cholesterol and VLDL-cholesterol were increased. An aqueous extract of Cleome droseriloia (500, 750 and 1000mg/Kg or Gliclazide (100mg/Kg) was administered orally once daily for two weeks to STZ-induced diabetic rats ameliorated hyperglycemia, improved lipid profile, amelioration of antioxidants and restored the metabolic enzymes of glucose to the normal value in the liver of STZ-treated rats. In addition, the administration of Cleome droserifolia induced the secretion of insulin from pancreatic rats. Furthermore, the hypoglycemic efficacy of one dose of aqueous extract Cleome droserifolia has extended to 12 hours. The effects produced by Cleome droserifolia extract were found to be comparable with that of gliclazide. Conclusion: The present results suggested that Cleome droserifolia could be used as antidiabetic complement of diabetes mellitus. This may be related to its insulin-induction action.

Еще

Cleome droserifolia, streptozotocin, insulin, glucose, lipids, metabolic enzymes, antioxidants

Короткий адрес: https://sciup.org/14323499

IDR: 14323499

Список литературы Hypoglycemic, hypolipidemic and antioxidant activities of Cleome droserifolia in streptozotocin-diabetic rats

  • Abou-Seif, MA. And Youssef, AA. 2004: Evaluation of some biochemical changes in the diabetic patients. Clin Chim Acta, 346: 161-170.
  • Agardh, CD.; Bjorgell, P. and Nilson, EP. 1999: The effect of tolbutamide on lipoproteins and lipoprotein lipase and hormone sensitive lipase. Diab Res Clin Pract, 46: 99-108.
  • Ahmed, I.; Lakhani, MS.; Gillett, M.; John, A. and Raza, H. 2001: Hypotriglyceridemic and hypocholesterolemic effects of antidiabetic Momordica charantia fruit extract in streptozotocin induced diabetic rats. Diabetes Res. Clin. Pract. 51(3): 155-161.
  • Aiston, S.; Trinh, KY.; Lang, AJ; Newgard, CB. And Agius, L. 1999: Glucose-6-phosphatase overexpression lowers glucose-6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase. J Biol Chem, 274: 24559-24566.
  • Ananthan, R.; Latha, M.; Ramkumar, KM.; Pari, L.; Baskar, C. and Narmatha, BV.2004: Antidiabetic effect of Gtmnema montanum leaves. Nutrition, 6: 379-386.
  • Andallu, B. and Varadacharyulu, N.C 2003: Antioxidant role of mulberry leaves in streptozotocin-diabetic rats. Clin Chim Acta, 338: 343.
  • Aria, K.; Lizuka, S.; Tada, Y.; Oikawa, K. and Taniguch,N. 1989: Increased in the glycosylated form of erythrocyte Cu, Znsuperoxide dismutase in diabetes and clse association of the nonenzymatic glucosylation with the enzyme activity. Biochem Biophys Acta, 924: 292-296.
  • Ashokkumar, N. and Pari, L. 2005: Effect of Nbenzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta, 351 (1-2): 105-113.
  • Baynes, JW. 1991: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
  • Baynes, JW. 1995: Reactive oxygen in the etiology and complications of diabetes. In Ioannides, C. and Flatt, PR.(eds.). Drug, diet and disease. Volume 2: mechanistic approach to diabetes. Hertfordshire: Ellis Horwood Limited 203-231.
  • Beutler, E.; Duron, O. and Kelly, MB 1963: Determination of blood glutathione. J Lab Clin Med, 61: 882-890.
  • Blum, J. and Fridovich, I. 1985: Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys, 240: 500-508.
  • Bucolo, G. and David, H. 1973: Enzymatic determination of serum triglycerides quantitatively. Clin Chem, 19: 475-481.
  • Chan TK.; Todd, D and Wong, CC. 1965: Tissue levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency. J Lab Clin Med, 6: 936-940.
  • Damsbo, P.; Vaag, A.; Hother-nielsen, O. and Beck-Nielsen, H.1991: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 diabetes mellitus. Diabetologia 34(4): 239-245.
  • Draper, W. and Hadley, M. 1990: Indirect determination of oxygen free radical. Methods Enzymol, 186: 421-431.
  • Ellefson, RD. and Caraway, WT. 1976: Fundamentals of clinical chemistry. Tietz, N.W. (ed.), pp 506-576.
  • Esterbauner, H.; Schaur, RJ. And Zollner, H. 1991: Chemistry and biochemistry of 4-hydroxynonenal, malondialehyde and related aldehydes. Free radical Biol Med, 11: 81-128.
  • Garg MC; Ojha, S. and Bansal, D.D 1996: Antioxidant status of streptozotocindiabetic rats. Indian J Exp Biol, 34: 264-271.
  • Gaskin, RS.; Estwick, D. and Peddi, R. 2001: G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus. Ethn Dis, 11: 749-754.
  • Ghosh, R.; Sharatchandra, KH.; Rita, S. and Thokchom, IS.2004: Hypoglycemic activity of Ficus hispida in normal and diabetic albino rats. Indian J of pharmacology, 36(4):222-225.
  • Giugliano, D.; Ceriello,A. and Paolisso, G. 1996: Oxidative stress diabetic vascular complications. Diabetes Care, 19:257-267.
  • Gordon, T.; Castelli, WP.; Hjortland, MC, Kannel, WB and Dawber, TR. 1977: High density lipoprotein in protective factor against coronary heart diseases, the Framingham study. Amer J Med, 62: 707-714.
  • Grune, T.; Siems, WG. Ad Petras, T. 1997: Identification of metabolic pathways of the lipid peroxidation product, 4-hydroxynonenal, in in situ perfused rat kidney. J Lipid Res, 38(8): 1660-1665.
  • Kamel, MS.; Ohtanti, K.; Kurokawa, T.; Assaf, MH.; El-Shanawany, MA.; Ali, AA.; Kasai, R. Ishibashi, S. and Tanaka, O.1991: Studies on Balanites aegyptaca fruits, an antidiabetic Egyptian folk medicine. Chem Pharm Bull, 39(5): 1229-1233.
  • Laaksonen, D.E. and Sen, C.K.2000: Exercise and oxidative stress diabetes mellitus. In: Handbook of oxidants and antioxidants in exercise, Sen, CK.; Packer, L. and Hanninen, O. (eds.), Amsterdam, Elsevier, pp 1105-1136.
  • Litchfield, JT and Wilcoxon, FA. 1949: Simplified method of evaluating dose effect experiments. J Pharmacol Exp Ther 96: 99-133.
  • Luzi, L. 1998: Pancreas transplantation and diabetic complications. New England J Med, 339: 115-117.
  • Maiti, R.; Jana, D.; Das, UK. And Ghosh, D. 2004: Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin -induced diabetic rats. J Ethnopharmacol, 92(1): 85-91.
  • Mclennan, SV.; Heffernan, S.; Wright, L.; Rae, C.; Fisher, E.;Yue, DK. And Turtle, J.1991: Change in hepatic glutathione metabolism in diabetes. Diabetes, 40: 344-348.
  • Mehta, A.; Mason, PJ. And Vulliamy, TJ. 2000: Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Res Clin Haematol, 13: 21-38.
  • Miller, G.T. 1991: Coronary heart disease and associated characteristics in tropical development community. Trans-R. Soc. Trop.Med. Hyp.,85: 324-335.
  • Montilla, p.; Barcos, M.; Munoz, MC; Munoz-Castaneda JR; Bujalance,I. and Tunez, I. 2004: Protective effect of Montilla-Moriles appellation red wine on oxidative stress induced by streptozotocin in the rat. J Nutr Biochem 15(11): 688-693.
  • Murray, RS. 1982: Schaum,s outline series of theory and problems of probability and statistics, Singapore, McGraw-Hill Book Company, vol, 8: pp 265-298.
  • Nishikimi, M.; Roa, NA. and Yogi, K. 1972: The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophy Res Commun, 46: 849-854.
  • Pari, L. and Latha, M. 2002: Effect of Cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med J 43: 617-621.
  • Prince PS.; Kamal, N. and Menon, VP. 2004: Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium Cumini seeds in alloxan induced diabetic albino rats. J Ethnopharmacol, 91: 209-213.
  • Rossetti, L.; Lee, YT; Ruiz, J.; Aldridge, S.;Shamoon, H and boden, G. 1993: Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol, 295: 761-769.
  • Scartezzini, P.; speroni, E. 2000: Review on some plants of Indian traditional medicine with antioxidant activity. J. Ethnopharmacol. 71: 23-43.
  • Seifter,S. and England, S. 1982: Energy metabolism. In: The liver; biology and pathology, Arias, I.;Papper, M. and Schacter, D. (eds.), New York, Reven Press, pp 219-249.
  • Sochor, M.;Baquer, NZ. And McLean, P.1985:Glucose over and under untilization in diabetes: comparative studies on the change in activities of enzymes of glucose metabolism in rat kidney and liver. Mol Physiol. 16:51-68.
  • Soto, CP.; Perez, BL.; Favari, LP.And Reyes, JL. 1998: prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 119(2): 125-129.
  • Sridhar, SB.; Sheetal, UD.; Pai, MR. and Shastri, MS. 2005: Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Brazilian J Med Biol Res, 38(3): 463-470.
  • Tiwari, AK. And Madhusudana, RJ, 2002: Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Current science, 83: 30-38.
  • L. Pari and S. Venkateswaran, Protective role of Phaseolus vulgaris on changes in the fatty acid composition in experimental diabetes, Journal of Medicinal Food 7 (2004), pp. 204-209.
  • T.E. Tenner Jr., X.J. Zhang and J.B. Lombardini, Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes, Advances in Experimental and Medical Biology 526 (2003), pp. 97-104.
  • Trinder, P. 1969: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem, 6: 24-27.
  • Zhang, XF. And Tab, BK. 2000: Antihyperglycemic and antioxidant properties of andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol physiol, 27: 358-363.
  • Beppu, H., Shimpo, K., Chihara, T., Kaneko, T., Tamai, I., Yamaji, S., Ozaki, S., Kuzuya, H., Sonoda, S., 2006. Antidiabetic effects of dietary administration of Aloe arborescens Miller components in multiple low-dose streptozotocin-induced diabetes in mice: Investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J. Ethnopharmacol. 103, 468-477.
  • Maiti, R., Das, U.K., Ghosh, D., 2005. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tarmarindus indica. Biol. Pharm. Bull. 28 (7), 1172-1176.
  • Montilla, M. Barcos, M.C. Munoz, J.R. Munoz-Castaneda, I. Bujalance and I. Tunez, Protective effect of Montilla-Moriles appellation red wine on oxidative stress induced by streptozotocin in the rat, The Journal of Nutritional Biochemistry 15 (2004), pp. 688-693.
  • Roy, R. Sehgal, B.M. Padhy and V.L. Kumar, Antioxidant and protective effect of latex of Calotropis procera against alloxaninduced diabetes in rats, Journal of Ethnopharmacology 102 (2005), pp. 470-473
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp